One thing I have actually learned as an investor is that a great product will drive the value of a company. There are various other concrete elements included, however without the good item the business will not go anywhere. I take pleasure in searching business and looking for one that I think could have the capacity for good growth in the future. These companies require a product that's visiting be given market and I think I have discovered one, in Biologix Hair, Inc (BLGX).
BLGX focuses on the therapy and avoidance of alopecia. Alopecia is the medical term for baldness, which is a multi-billion dollar sector, $3.5 billion in the United States alone. The company's item, Biologix Hair Treatment System , takes a various approach to trigger and therapy then its 2 major rivals on the marketplace today.
Let's have a look at the business's initial method to hair loss, treatment, and competitors.
Biologix Hair, Inc
. Trading at $2.60. Market Cap- $221.4 million
. Initial Research and Therapy.
In South America, Dr. Duran and a team of exclusive clinicians offered "preclinical trial treatments" to 5,000 clients in a scientifically controlled environment over a five-year period. Below are the approximated results for this preclinical trial of therapy:.
Throughout those 8 years, the clinicians subjectively approximated that healthy hair development has been kept in practically 100 % of individuals whose objective was to prevent the beginning of Follicle Nutrient Insufficiency Syndrome (FNDS) and resulting alopecia.
Between 80-- 85 % of their male patients and upwards of 90 % of their female clients being treated for FNDS and looking for hair regeneration therapy have had the ability to re-grow their lost hair.
Biologix Revive hair formula greatly decreases or gets rid of the inflammation and encapsulation of the hair follicles, which enables the nutrients, minerals and vitamins within the formula to restore those dormant hair follicles.
Unlike the items on the marketplace now, hair rejuvenation treatment is administered through injection, which I talk about later on in even more detail. It is conducted month-to-month for four to six months then bimonthly to strengthen ongoing new development. Research recommends two times a year follow-up check outs for upkeep.
Why injections instead of topical? Dr. Durand's team identified that topical therapies have an extremely shallow penetration level between.3 and.4 MM optimum. However the issue lies at the root inside the hair follicle, which is 3 to 4 MM deep. For this reason they opted to utilize injections into the follicle root layer in their preclinical trials.
Dr. Duran and his group method their research from the premise that follicles that were not growing exist in a "dormant state." Research was originally done to determine the biological processes involved and matching effects upon follicles that would develop a possible prevention and renovation procedure.
As an investor, it is a good concept to understand how this company's hair growth therapy program works and to understand its vision for the future.
Cycle of Hair Grow.
Stage I-- Anagen (I, II and III): active development phase throughout which brand-new hair shaft kinds, pushes out old shaft and arises from follicle aperture on scalp.
Stage II-- Catagen: transitional phase throughout which hair follicle reduces, dermal papilla escape from hair shaft and inactivates.
Stage III-- Telogen: called a resting stage, hairs are quickly dropped at this point.
Stage IV-- Exogen: dropping of the old hair. After a short time period, the hair follicle go back to Anagen I and the cycle is duplicated.
Its current research and development phase with a leading university ought to take about 12 months to finish. Hair follicles do not expand in unison and might be in different stages of development, and this is the means hair regrows itself. In their research, Dr. Duran figures out that it's the 3rd stage or the "telogen" phase that triggers "Follicle Nutrient Deficiency Disorder." A collagen band forms from the base of the follicle therefore limiting or badly weakening hair growth.
By injecting into the hair root follicle, the corresponding nutrients help "revive" the hair follicle and works on getting rid of the "collagen band". As a result, the inactive hair follicle returns to life and begins growing typically once again.
Working on FDA Approval.
The business is focused on obtaining FDA approval for its hair thinning prevention and regeneration treatment. Currently it is spending about YEAR finishing its R&D program dealing with the Beijing Institute of Innovation, which is the last step before formal medical trials and the beginning of the FDA approval process.
While this is taking place the management team is figured out to be prepared to place itself to capitalize on high-margin sales from the Biologix Hair Therapy System, if and when the FDA and various other major markets provide last approval. The number of certified medical facilities that have signed contractual bookings to become certified for the therapy system is now up to 276. The estimated variety of existing patients would like either the hair thinning avoidance or regrowth treatment and are candidates for the Biologix Hair Treatment System has actually climbed to over 1,300,000 patients.
Biologix Hair Science Ltd. , is visiting open a company had and operated Biologix Hair Treatment Centerin Cartagena, Colombia before the end of October.
The center will offer its patent pending hair loss treatment for the first time, which will permit the business to begin producing revenue. The treatment center will likewise double as a training center for qualified clinicians who have contract with the company to offer these sorts of hair centers. This will serve as a prototype for future centers that will not be run by the business but by the clinicians themselves.
Dr. Diego Castresana, Vice President of Research and Development for Biologix Hair Science Ltd. had this to say about the convenience of the Center's location, "Being based here enables me to personally supervise center operations to guarantee the highest standards possible are continually met. And with direct air travels from major around the world flight terminals, it is also hassle-free for medical practitioners to go to and receive official training.".
Competition.
From an investor's point of view is necessary to understand that Biologix has competition from 2 well-known worldwide companies you might be knowledgeable about, Merck and Johnson & Johnson. In between them lies a $460 million industry.
Merck $MRK has a baldness product referred to as Propecia that produces about $400 million yearly for the company. The item works by shutting out the formation of particular sorts of male pattern hair loss. It reduces the formation of DHT in the scalp that further inhibits the shrinking of the affected hair follicles.
Does it work?
Wishing to know if Propecia really worked, a research was performed for guys who lost hair on the top of their head. Guy who took the Propecia expanded brand-new hair while those on the placebo didn't. After about a year brand-new hair growth stopped and they gradually started to lose it once again but the loss rate was much lower than those who had the placebo. Right here are the long-lasting statistics after five years:.
48 % of men had actually increased hair development.
42 % had no change (the hair thinning had actually stopped).
10 % had actually lost hair.
On the placebo, 75 % had actually lost hair after five years.
As soon as guys stopped taking Propecia, the useful benefits for baldness wore off over one year.
Its active component is finasteride.
Among the problems for guys with Propecia is the sexual side effect caused by finasteride. In fact, 1,52
BLGX focuses on the therapy and avoidance of alopecia. Alopecia is the medical term for baldness, which is a multi-billion dollar sector, $3.5 billion in the United States alone. The company's item, Biologix Hair Treatment System , takes a various approach to trigger and therapy then its 2 major rivals on the marketplace today.
Let's have a look at the business's initial method to hair loss, treatment, and competitors.
Biologix Hair, Inc
. Trading at $2.60. Market Cap- $221.4 million
. Initial Research and Therapy.
In South America, Dr. Duran and a team of exclusive clinicians offered "preclinical trial treatments" to 5,000 clients in a scientifically controlled environment over a five-year period. Below are the approximated results for this preclinical trial of therapy:.
Throughout those 8 years, the clinicians subjectively approximated that healthy hair development has been kept in practically 100 % of individuals whose objective was to prevent the beginning of Follicle Nutrient Insufficiency Syndrome (FNDS) and resulting alopecia.
Between 80-- 85 % of their male patients and upwards of 90 % of their female clients being treated for FNDS and looking for hair regeneration therapy have had the ability to re-grow their lost hair.
Biologix Revive hair formula greatly decreases or gets rid of the inflammation and encapsulation of the hair follicles, which enables the nutrients, minerals and vitamins within the formula to restore those dormant hair follicles.
Unlike the items on the marketplace now, hair rejuvenation treatment is administered through injection, which I talk about later on in even more detail. It is conducted month-to-month for four to six months then bimonthly to strengthen ongoing new development. Research recommends two times a year follow-up check outs for upkeep.
Why injections instead of topical? Dr. Durand's team identified that topical therapies have an extremely shallow penetration level between.3 and.4 MM optimum. However the issue lies at the root inside the hair follicle, which is 3 to 4 MM deep. For this reason they opted to utilize injections into the follicle root layer in their preclinical trials.
Dr. Duran and his group method their research from the premise that follicles that were not growing exist in a "dormant state." Research was originally done to determine the biological processes involved and matching effects upon follicles that would develop a possible prevention and renovation procedure.
As an investor, it is a good concept to understand how this company's hair growth therapy program works and to understand its vision for the future.
Cycle of Hair Grow.
Stage I-- Anagen (I, II and III): active development phase throughout which brand-new hair shaft kinds, pushes out old shaft and arises from follicle aperture on scalp.
Stage II-- Catagen: transitional phase throughout which hair follicle reduces, dermal papilla escape from hair shaft and inactivates.
Stage III-- Telogen: called a resting stage, hairs are quickly dropped at this point.
Stage IV-- Exogen: dropping of the old hair. After a short time period, the hair follicle go back to Anagen I and the cycle is duplicated.
Its current research and development phase with a leading university ought to take about 12 months to finish. Hair follicles do not expand in unison and might be in different stages of development, and this is the means hair regrows itself. In their research, Dr. Duran figures out that it's the 3rd stage or the "telogen" phase that triggers "Follicle Nutrient Deficiency Disorder." A collagen band forms from the base of the follicle therefore limiting or badly weakening hair growth.
By injecting into the hair root follicle, the corresponding nutrients help "revive" the hair follicle and works on getting rid of the "collagen band". As a result, the inactive hair follicle returns to life and begins growing typically once again.
Working on FDA Approval.
The business is focused on obtaining FDA approval for its hair thinning prevention and regeneration treatment. Currently it is spending about YEAR finishing its R&D program dealing with the Beijing Institute of Innovation, which is the last step before formal medical trials and the beginning of the FDA approval process.
While this is taking place the management team is figured out to be prepared to place itself to capitalize on high-margin sales from the Biologix Hair Therapy System, if and when the FDA and various other major markets provide last approval. The number of certified medical facilities that have signed contractual bookings to become certified for the therapy system is now up to 276. The estimated variety of existing patients would like either the hair thinning avoidance or regrowth treatment and are candidates for the Biologix Hair Treatment System has actually climbed to over 1,300,000 patients.
Biologix Hair Science Ltd. , is visiting open a company had and operated Biologix Hair Treatment Centerin Cartagena, Colombia before the end of October.
The center will offer its patent pending hair loss treatment for the first time, which will permit the business to begin producing revenue. The treatment center will likewise double as a training center for qualified clinicians who have contract with the company to offer these sorts of hair centers. This will serve as a prototype for future centers that will not be run by the business but by the clinicians themselves.
Dr. Diego Castresana, Vice President of Research and Development for Biologix Hair Science Ltd. had this to say about the convenience of the Center's location, "Being based here enables me to personally supervise center operations to guarantee the highest standards possible are continually met. And with direct air travels from major around the world flight terminals, it is also hassle-free for medical practitioners to go to and receive official training.".
Competition.
From an investor's point of view is necessary to understand that Biologix has competition from 2 well-known worldwide companies you might be knowledgeable about, Merck and Johnson & Johnson. In between them lies a $460 million industry.
Merck $MRK has a baldness product referred to as Propecia that produces about $400 million yearly for the company. The item works by shutting out the formation of particular sorts of male pattern hair loss. It reduces the formation of DHT in the scalp that further inhibits the shrinking of the affected hair follicles.
Does it work?
Wishing to know if Propecia really worked, a research was performed for guys who lost hair on the top of their head. Guy who took the Propecia expanded brand-new hair while those on the placebo didn't. After about a year brand-new hair growth stopped and they gradually started to lose it once again but the loss rate was much lower than those who had the placebo. Right here are the long-lasting statistics after five years:.
48 % of men had actually increased hair development.
42 % had no change (the hair thinning had actually stopped).
10 % had actually lost hair.
On the placebo, 75 % had actually lost hair after five years.
As soon as guys stopped taking Propecia, the useful benefits for baldness wore off over one year.
Its active component is finasteride.
Among the problems for guys with Propecia is the sexual side effect caused by finasteride. In fact, 1,52
SHARE
